CONMED Corporation to Announce First Quarter 2022 Financial Results on April 27, 2022
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2022 after...
Day: April 1, 2022
6 Dosell are Implemented in a New Municipality
STOCKHOLM, SWEDEN / ACCESSWIRE / April 1, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group (publ.) hereby announces that the partner Careium...
Love Hemp Group PLC Announces Response to the Latest FSA Novel Foods Update
LONDON, UK / ACCESSWIRE / April 1, 2022 / Love Hemp Group PLC (AQSE:LIFE)(OTCQB:WRHLF), the brand-led consumer goods company focussed...
Angle PLC Announces Identifying Drug Targets in Cancer Metastasis
PARSORTIX SYSTEM DEMONSTRATES ABILITY TO ISOLATE CTCs FOR DOWNSTREAM MOLECULAR ANALYSIS, IDENTIFYING KEY DRUG TARGETS INVOLVED IN CANCER METASTASISWorld-class research...
Relief Therapeutics Announces that its Subsidiary was Issued a Swiss Patent Entitled ‘Vasoactive Intestinal Peptide (VIP) for the Use in the Treatment of Drug-induced Pneumonitis’
GENEVA, SWITZERLAND / ACCESSWIRE / April 1, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (" Relief "), a biopharmaceutical company...
Spexis Publishes Invitation to Annual General Meeting 2022
Ad hoc announcement pursuant to Art. 53 LR- Pre-AGM information call on April 7, 2022 at 2:30PM CET- AGM to...
Relief Reports that its U.S. Collaboration Partner has Announced that the I-SPY COVID Trial Suggests No Clinical Benefit with Addition of Nebulized Aviptadil in Critically Ill Patients with COVID-19
GENEVA, SWITZERLAND / ACCESSWIRE / April 1, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (" Relief "), a biopharmaceutical company...
XPhyto Closes First Tranche of Financing
VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / March 31, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company")...